Merrion Investment Management Co, LLC Bristol Myers Squibb CO Transaction History

Merrion Investment Management Co, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	SELL	$63.71 - $70.74 $38,226 - $42,444	-600 Reduced 8.81%	6,210 $397,000
Q1 2023 Apr 06, 2023	SELL	$65.71 - $74.53 $11,499 - $13,042	-175 Reduced 2.51%	6,810 $472,000
Q3 2022 Oct 17, 2022	SELL	$0.13 - $76.84 $65 - $38,420	-500 Reduced 6.68%	6,985 $496,000
Q4 2021 Feb 03, 2022	SELL	$53.63 - $62.52 $53,630 - $62,520	-1,000 Reduced 11.79%	7,485 $466,000
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $11,834 - $13,862	200 Added 2.41%	8,485 $502,000
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $30,955 - $33,710	-500 Reduced 5.69%	8,285 $553,000
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $507,245 - $574,802	8,785 New	8,785 $545,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Merrion Investment Management Co, LLC, based on Form 13F filings with the SEC.

Stay updated on Merrion Investment Management Co, LLC with notifications on news.